Cargando…

Autoimmune Pulmonary Alveolar Proteinosis during the Treatment of Idiopathic Inflammatory Myopathy

Approximately 50% of idiopathic inflammatory myopathies (IIMs) are associated with interstitial lung disease (ILD). Typically, IIM-ILD manifests as nonspecific interstitial pneumonia. We herein report a rare case of a 78-year-old man with autoimmune pulmonary alveolar proteinosis (PAP) that develope...

Descripción completa

Detalles Bibliográficos
Autores principales: Shijubou, Naoki, Sawai, Takeyuki, Hatakeyama, Taku, Munakata, Satoru, Yamazoe, Masami, Chiba, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970810/
https://www.ncbi.nlm.nih.gov/pubmed/35831113
http://dx.doi.org/10.2169/internalmedicine.9558-22
_version_ 1784897974240804864
author Shijubou, Naoki
Sawai, Takeyuki
Hatakeyama, Taku
Munakata, Satoru
Yamazoe, Masami
Chiba, Hirofumi
author_facet Shijubou, Naoki
Sawai, Takeyuki
Hatakeyama, Taku
Munakata, Satoru
Yamazoe, Masami
Chiba, Hirofumi
author_sort Shijubou, Naoki
collection PubMed
description Approximately 50% of idiopathic inflammatory myopathies (IIMs) are associated with interstitial lung disease (ILD). Typically, IIM-ILD manifests as nonspecific interstitial pneumonia. We herein report a rare case of a 78-year-old man with autoimmune pulmonary alveolar proteinosis (PAP) that developed during IIM treatment. The diagnosis of autoimmune PAP was based on detecting anti-granulocyte-macrophage colony-stimulating factor antibodies. We postulated that PAP may have been induced by IIM treatment with prednisolone. Our case suggests that the possibility of autoimmune PAP should be considered in patients with lung lesions during the clinical course of IIM.
format Online
Article
Text
id pubmed-9970810
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-99708102023-02-28 Autoimmune Pulmonary Alveolar Proteinosis during the Treatment of Idiopathic Inflammatory Myopathy Shijubou, Naoki Sawai, Takeyuki Hatakeyama, Taku Munakata, Satoru Yamazoe, Masami Chiba, Hirofumi Intern Med Case Report Approximately 50% of idiopathic inflammatory myopathies (IIMs) are associated with interstitial lung disease (ILD). Typically, IIM-ILD manifests as nonspecific interstitial pneumonia. We herein report a rare case of a 78-year-old man with autoimmune pulmonary alveolar proteinosis (PAP) that developed during IIM treatment. The diagnosis of autoimmune PAP was based on detecting anti-granulocyte-macrophage colony-stimulating factor antibodies. We postulated that PAP may have been induced by IIM treatment with prednisolone. Our case suggests that the possibility of autoimmune PAP should be considered in patients with lung lesions during the clinical course of IIM. The Japanese Society of Internal Medicine 2022-07-14 2023-02-01 /pmc/articles/PMC9970810/ /pubmed/35831113 http://dx.doi.org/10.2169/internalmedicine.9558-22 Text en Copyright © 2023 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Shijubou, Naoki
Sawai, Takeyuki
Hatakeyama, Taku
Munakata, Satoru
Yamazoe, Masami
Chiba, Hirofumi
Autoimmune Pulmonary Alveolar Proteinosis during the Treatment of Idiopathic Inflammatory Myopathy
title Autoimmune Pulmonary Alveolar Proteinosis during the Treatment of Idiopathic Inflammatory Myopathy
title_full Autoimmune Pulmonary Alveolar Proteinosis during the Treatment of Idiopathic Inflammatory Myopathy
title_fullStr Autoimmune Pulmonary Alveolar Proteinosis during the Treatment of Idiopathic Inflammatory Myopathy
title_full_unstemmed Autoimmune Pulmonary Alveolar Proteinosis during the Treatment of Idiopathic Inflammatory Myopathy
title_short Autoimmune Pulmonary Alveolar Proteinosis during the Treatment of Idiopathic Inflammatory Myopathy
title_sort autoimmune pulmonary alveolar proteinosis during the treatment of idiopathic inflammatory myopathy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970810/
https://www.ncbi.nlm.nih.gov/pubmed/35831113
http://dx.doi.org/10.2169/internalmedicine.9558-22
work_keys_str_mv AT shijubounaoki autoimmunepulmonaryalveolarproteinosisduringthetreatmentofidiopathicinflammatorymyopathy
AT sawaitakeyuki autoimmunepulmonaryalveolarproteinosisduringthetreatmentofidiopathicinflammatorymyopathy
AT hatakeyamataku autoimmunepulmonaryalveolarproteinosisduringthetreatmentofidiopathicinflammatorymyopathy
AT munakatasatoru autoimmunepulmonaryalveolarproteinosisduringthetreatmentofidiopathicinflammatorymyopathy
AT yamazoemasami autoimmunepulmonaryalveolarproteinosisduringthetreatmentofidiopathicinflammatorymyopathy
AT chibahirofumi autoimmunepulmonaryalveolarproteinosisduringthetreatmentofidiopathicinflammatorymyopathy